MACULA RESEARCH

Group leader


macular-banner [F]oxymoron Angelo Juan Ramos David Rouhani Lori Greig Pete Fang Guo Ryan Kitko cursedthing GoRun26 @ Flikr David Rouhani


The Macular Research Group (formerly known as the Retinal Therapeutics Research Unit) is based at the Save Sight Institute on the campus of the Sydney Eye Hospital. Our mission is to develop new treatments that will reduce the prevalence of blindness from macular disease, through multidisciplinary, patient oriented, world class research. The group is headed by Professor Mark Gillies and is made up of two cohesive research units -

CLINICAL RESEARCH UNIT

LABORATORY RESEARCH UNIT

FIGHT RETINAL BLINDNESS!

Overview

Overview

Aim

Current & Upcoming Trials

Projects

Collaboration

Macular Degeneration

Studies on Müller glia-neuron and vascular interactions using inducible and Müller cell-specific gene targeting mice

Background

Cystoid Macular Oedema

Metabolic dysfunction and Retinal Diseases

Key Activities

Diabetic Retinopathy

The distinct roles of Müller cells in central and peripheral human retina

Progress

Diabetic Macular Oedema

The Role of TLR-mediated Neuroinflammation in Retinal Disease

Outcomes

Branch Retinal Vein Occlusion

Differential expression of microRNAs in a murine model of selective Müller cell ablation

FRB! Video

Central Retinal Vein Occlusion

The contribution of aberrant Wnt signaling to neuronal and vascular pathology in retinal disease

Publications

Macular Telangiectasia

Dysregulation of interphotoreceptor retinoid binding protein in the pathogenesis of retinal disease

 

Make an Appointment

Use patient-derived stem cells to treat and model macular diseases

 

Refer a Patient

Recent Publications

 

Receive Trial Updates

Find Us

 

Publications

Contact Us

 

Find Our Clinics

 

 

Contact Us

 

 


Our Staff